NCT03356639 A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT03355781 Childhood Trauma in Schizophrenia: Exploration of Links Between Gene Expression, Cerebral Morphology and Symptomatology Status COMPLETED Phase N/A
NCT03351244 This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months Status TERMINATED Phase PHASE2
NCT03345979 A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia Status COMPLETED Phase PHASE3
NCT03333603 Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients Status COMPLETED Phase PHASE4
NCT03316664 Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis Status COMPLETED Phase NA
NCT03314129 Remediation of Visual Perceptual Impairments in People With Schizophrenia Status COMPLETED Phase NA
NCT03304457 Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia Status COMPLETED Phase PHASE4
NCT03302364 A Research in Pharmacogenomics and Accurate Medication of Risperidone Status UNKNOWN Phase N/A
NCT03287505 Aripiprazole IM Depot for Chinese Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT03285503 PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia Status COMPLETED Phase PHASE1
NCT03284294 Influence of Vitamin D Supplementation on Serum BDNF Level and Cognitive Function in Schizophrenia Status UNKNOWN Phase PHASE3